[Recommendations for clinical practice of the CNGOF on the prevention of Rhesus alloimmunisation in the 1st trimester: Is de-escalation really reasonable?]

Authors

Jeremy Boujenah, Département d'obstétrique, GH Diaconesses Croix Saint-Simon, 75019 Paris, France; Centre médical du château, Vincennes, France. Electronic address: Jeremy.boujenah@gmail.com.
Kenneth J. Moise, Department of Women's Health, Dell Medical School, UT Health Austin, and the Comprehensive Fetal Center, Dell Children's Medical Center, Austin, Texas, États-Unis; Department of Obstetrics and Gynecology, Bridgeport Hospital/Yale University, Bridgeport, Connecticut, États-Unis.
Claude d'Ercole, Service de Gynécologie Obstétrique, hôpital Nord, chemin des Bourrely, 13015 Marseille, France.
Bruno Carbonne, Centre Hospitalier Princesse Grace, Monaco.

Document Type

Editorial

Publication Title

Gynecologie, obstetrique, fertilite & senologie

DOI

10.1016/j.gofs.2024.09.008

Publication Date

10-10-2024

Recommended Citation

Boujenah, Jeremy; Moise, Kenneth J.; d'Ercole, Claude; and Carbonne, Bruno, "[Recommendations for clinical practice of the CNGOF on the prevention of Rhesus alloimmunisation in the 1st trimester: Is de-escalation really reasonable?]" (2024). Obstetrics and Gynecology. 1.
https://scholar.bridgeporthospital.org/obgyn/1

Identifier

39393641 (pubmed); 10.1016/j.gofs.2024.09.008 (doi); S2468-7189(24)00301-5 (pii)